154 related articles for article (PubMed ID: 6481182)
1. Activation of the alternative complement pathway by Fonsecaea pedrosoi.
Torinuki W; Okohchi K; Takematsu H; Tagami H
J Invest Dermatol; 1984 Oct; 83(4):308-10. PubMed ID: 6481182
[TBL] [Abstract][Full Text] [Related]
2. Activation of complement by 405-nm light in serum from porphyria cutanea tarda.
Torinuki W; Miura T; Tagami H
Arch Dermatol Res; 1985; 277(3):174-8. PubMed ID: 4015182
[TBL] [Abstract][Full Text] [Related]
3. Stratum corneum activation of complement through the antibody-independent alternative pathway.
Terui T; Kato T; Tagami H
J Invest Dermatol; 1989 Apr; 92(4):593-7. PubMed ID: 2649596
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of skin test for chromoblastomycosis using antigens prepared from culture filtrates of Fonsecaea pedrosoi, Phialophora verrucosa, Wangiella dermatitidis and Exophiala jeanselmei.
Iwatsu T; Miyaji M; Taguchi H; Okamoto S
Mycopathologia; 1982 Jan; 77(1):59-64. PubMed ID: 7070478
[TBL] [Abstract][Full Text] [Related]
5. Complement activation in type 1 human diabetes.
Sundsmo JS; Papin RA; Wood L; Hirani S; Waldeck N; Buckingham B; Kershnar A; Ascher M; Charles MA
Clin Immunol Immunopathol; 1985 May; 35(2):211-25. PubMed ID: 3907907
[TBL] [Abstract][Full Text] [Related]
6. Activation of the alternative complement pathway in normal human serum by Loa loa and Brugia malayi infective stage larvae.
Yates JA; Higashi GI; Lowichik A; Orihel TC; Lowrie RC; Eberhard ML
Acta Trop; 1985 Jun; 42(2):157-63. PubMed ID: 2862778
[TBL] [Abstract][Full Text] [Related]
7. Activation of the alternative complement pathway by intraocular lenses.
Mondino BJ; Nagata S; Glovsky MM
Invest Ophthalmol Vis Sci; 1985 Jun; 26(6):905-8. PubMed ID: 4008203
[TBL] [Abstract][Full Text] [Related]
8. Complement activation by trichophyton rubrum.
Swan JW; Dahl MV; Coppo PA; Hammerschmidt DE
J Invest Dermatol; 1983 Mar; 80(3):156-8. PubMed ID: 6827124
[TBL] [Abstract][Full Text] [Related]
9. How do complement components and fragments affect cellular immunological function?
Gelfand JA
J Trauma; 1984 Sep; 24(9 Suppl):S118-24. PubMed ID: 6332921
[No Abstract] [Full Text] [Related]
10. Complement activating property of the protein-rich endotoxin (OEP) of Pseudomonas aeruginosa. I. Activation of both the classical and the alternative pathways of guinea pig complement.
Inada K
Jpn J Exp Med; 1980 Feb; 50(1):13-21. PubMed ID: 6770130
[TBL] [Abstract][Full Text] [Related]
11. Activation of complement by blood transfusion filters.
Snyder EL; Root RK; McLeod B; Dalmasso AP
Vox Sang; 1983; 45(4):288-93. PubMed ID: 6636655
[TBL] [Abstract][Full Text] [Related]
12. Melanin particles isolated from the fungus Fonsecaea pedrosoi activates the human complement system.
Pinto L; Granja LFZ; Almeida MA; Alviano DS; Silva MHD; Ejzemberg R; Rozental S; Alviano CS
Mem Inst Oswaldo Cruz; 2018 Jun; 113(8):e180120. PubMed ID: 29947713
[TBL] [Abstract][Full Text] [Related]
13. Complement activation by pneumococci associated with acute otitis media.
Prellner K
Acta Pathol Microbiol Scand C; 1979 Jun; 87C(3):213-6. PubMed ID: 39420
[TBL] [Abstract][Full Text] [Related]
14. The activation of C5 in the fluid phase and in the absence of C3 through the classical pathway of the complement system.
Kitamura H; Tsuboi M; Nagaki K
Immunology; 1986 Jul; 58(3):459-65. PubMed ID: 3733147
[TBL] [Abstract][Full Text] [Related]
15. Complement activation during systemic lupus erythematosus. C3a and C5a anaphylatoxins circulate during exacerbations of disease.
Belmont HM; Hopkins P; Edelson HS; Kaplan HB; Ludewig R; Weissmann G; Abramson S
Arthritis Rheum; 1986 Sep; 29(9):1085-9. PubMed ID: 3489467
[TBL] [Abstract][Full Text] [Related]
16. Incompatibility between complement components C3 and C5 of guinea-pig and man, an indication of their interaction in C5 activation by classical and alternative C5 convertases.
Von Zabern I; Nolte R; Vogt W
Scand J Immunol; 1979; 9(1):69-74. PubMed ID: 419365
[TBL] [Abstract][Full Text] [Related]
17. Alternative complement pathway-dependent ingestion of fluolite particles by human granulocytes.
Arnaout MA; Luscinskas FW; Lionetti FJ; Alper CA; Valeri CR
J Immunol; 1981 Jul; 127(1):278-81. PubMed ID: 6787126
[TBL] [Abstract][Full Text] [Related]
18. Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity.
Fick RB; Robbins RA; Squier SU; Schoderbek WE; Russ WD
Pediatr Res; 1986 Dec; 20(12):1258-68. PubMed ID: 3540828
[TBL] [Abstract][Full Text] [Related]
19. Transformation of Fonsecaea pedrosoi into sclerotic cells links to the refractoriness of experimental chromoblastomycosis in BALB/c mice via a mechanism involving a chitin-induced impairment of IFN-γ production.
Dong B; Tong Z; Li R; Chen SC; Liu W; Liu W; Chen Y; Zhang X; Duan Y; Li D; Chen L
PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006237. PubMed ID: 29481557
[TBL] [Abstract][Full Text] [Related]
20. The release of C5a in complement-activated serum does not require C6.
Biesecker G; Wagner JL; Hugli TE
J Immunol; 1989 Aug; 143(4):1228-32. PubMed ID: 2545783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
